| Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study M Gilbert, G Pullano, F Pinotti, E Valdano, C Poletto, PY Boëlle, ... The Lancet 395 (10227), 871-877, 2020 | 1403 | 2020 |
| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 896 | 2021 |
| Evidence of sexual transmission of Zika virus E D’Ortenzio, S Matheron, X de Lamballerie, B Hubert, G Piorkowski, ... New England Journal of Medicine 374 (22), 2195-2198, 2016 | 818 | 2016 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 452 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 339 | 2021 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 280 | 2021 |
| Risk factors and predictors of severe leptospirosis in New Caledonia S Tubiana, M Mikulski, J Becam, F Lacassin, P Lefèvre, AC Gourinat, ... PLoS neglected tropical diseases 7 (1), e1991, 2013 | 177 | 2013 |
| Rift valley fever, Mayotte, 2007–2008 D Sissoko, C Giry, P Gabrie, A Tarantola, F Pettinelli, L Collet, ... Emerging infectious diseases 15 (4), 568, 2009 | 173 | 2009 |
| Chikungunya Virus and the Mosquito Vector Aedes aegypti in New Caledonia (South Pacific Region) M Dupont-Rouzeyrol, V Caro, L Guillaumot, M Vazeille, E d'Ortenzio, ... Vector-Borne and Zoonotic Diseases 12 (12), 1036-1041, 2012 | 152 | 2012 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 132 | 2022 |
| Long-lasting persistence of Zika virus in semen S Matheron, E d'Ortenzio, I Leparc-Goffart, B Hubert, X de Lamballerie, ... Clinical Infectious Diseases 63 (9), 1264-1264, 2016 | 90 | 2016 |
| The Jarisch-Herxheimer reaction in leptospirosis: a systematic review G Guerrier, E D’Ortenzio PloS one 8 (3), e59266, 2013 | 89 | 2013 |
| COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study Infection 49 (5), 889-905, 2021 | 86 | 2021 |
| Prevention of Ebola virus disease through vaccination: where we are in 2018 Y Lévy, C Lane, P Piot, AH Beavogui, M Kieh, B Leigh, S Doumbia, ... The Lancet 392 (10149), 787-790, 2018 | 80 | 2018 |
| Epidemiology of Chikungunya infection on Reunion Island, Mayotte, and neighboring countries P Renault, E Balleydier, E D’Ortenzio, M Bâville, L Filleul Medecine et maladies infectieuses 42 (3), 93-101, 2012 | 79 | 2012 |
| Prolonged Plasmodium falciparum infection in immigrants, Paris E D’Ortenzio, N Godineau, A Fontanet, S Houze, O Bouchaud, ... Emerging infectious diseases 14 (2), 323, 2008 | 78 | 2008 |
| Machine learning for COVID-19 needs global collaboration and data-sharing N Peiffer-Smadja, R Maatoug, FX Lescure, E D’ortenzio, J Pineau, ... Nature Machine Intelligence 2 (6), 293-294, 2020 | 73 | 2020 |
| Human plague: An old scourge that needs new answers X Vallès, NC Stenseth, C Demeure, P Horby, PS Mead, O Cabanillas, ... PLoS neglected tropical diseases 14 (8), e0008251, 2020 | 69 | 2020 |
| The emm-Cluster Typing System for Group A Streptococcus Identifies Epidemiologic Similarities Across the Pacific Region N Baroux, E d'Ortenzio, N Amédéo, C Baker, B Ali Alsuwayyid, ... Clinical infectious diseases 59 (7), e84-e92, 2014 | 68 | 2014 |
| Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives Q Le Hingrat, B Visseaux, C Laouenan, S Tubiana, L Bouadma, ... Clinical Microbiology and Infection 27 (5), 789. e1-789. e5, 2021 | 65 | 2021 |
